Evaluating lipid-lowering drug targets for Parkinson disease prevention with Mendelian randomization
View/ Open
Submitted version
Embargoed until: 5555-01-01
Reason: Unidentified version
Embargoed until: 5555-01-01
Reason: Unidentified version
Pagination
2020.05.04.20090142 - ?
DOI
10.1101/2020.05.04.20090142
Journal
medRxiv